annb0t
Top 20
ResMed Inc.âs RMD adjusted earnings per share (EPS) in the third quarter of fiscal 2023 were $1.68, up 27.3% year over year. The metric beat the Zacks Consensus Estimate by 7%.
The adjustments include certain non-recurring expenses/benefits like the amortization of acquired intangibles and acquisition-related expenses, among others.
GAAP EPS in the reported quarter was $1.58, up 29.5% from the year-ago quarterâs EPS.
Revenues
Fiscal third-quarter revenues on a reported basis increa...
>>> Read more: ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates
The adjustments include certain non-recurring expenses/benefits like the amortization of acquired intangibles and acquisition-related expenses, among others.
GAAP EPS in the reported quarter was $1.58, up 29.5% from the year-ago quarterâs EPS.
Revenues
Fiscal third-quarter revenues on a reported basis increa...
>>> Read more: ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates
